An historical survey of UK government measures to control the NHS medicines expenditure from 1948 to 1996

PharmacoEconomics

Volumn 10, Issue 3, 1996, Pages 210-224

  Griffin, John P ^a,b,c,d  

^a John Griffin Associates Ltd   (United Kingdom)

^b Medicines Division   (United Kingdom)

^c ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY   (United Kingdom)

^d Quartermans   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COST CONTROL; HISTORY; HUMAN; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; UNITED KINGDOM;

EID: 0029744635     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-199610030-00003     Document Type: Review

References (37)

1. Timmins N. The Five Giants. London: Harper Collins, 1995: 131
2. Campbell J. Nye Bevan. London: Hodder & Stoughton, 1987: 182-3
3. Timmins N. The Five Giants. London: Harper Collins, 1995: 158
4. Chew R. Compendium of Health Statistics, 9th ed. London: Office of Health Economics, 1995
5. Department of Health. Prescription Pricing Authority Annual Reports 1994/5. London: Her Majesty's Stationery Office, 1995
6. Griffin JR. The impact of unemployment on health. London: Office of Health Economics: 1993. Briefing No. 29
7. Warden J. Men can have free prescriptions at 60. BMJ 1995; 311: 1118
8. Griffin TD. Patient contribution to the cost of prescribed medicines in Europe. In: Griffin JP, O'Grady J, Wells FO, editors. The textbook of pharmaceutical medicine, 2nd ed. Belfast: Queens University of Belfast, 1995: 581-94
9. Griffin JP. Increasing cost of medicines. Lancet 1993; 341: 1156-7
10. Green DG, Lucas DA. Medicard: a better way to pay for medicines, London: Institute of Economic Affairs Health and Welfare Unit, 1993. (Choice in Welfare: 16)
11. The Pharmaceutical Price Regulation Scheme 1993. HMSO London. Department of Health. Reference no. Del DH 004643, 9/93
12. Association of the British Pharmaceutical Industry. A guide to the Pharmaceutical Price Regulation Scheme PPRS 1993. London: Association of the British Pharmaceutical Industry, 1993
13. Abolish PPRS says Merck. Scrip 1994 Oct 29; (1969): 6
14. European Commission Council Directive 92/97 EHC on the Labelling of Medicinal Products for Human Use and on Package Leaflets. J Eur Communities 1992
15. Griffin JP. Generic prescribing. Pharmatopics No. 8. London: ABPI, 1986
16. Department of Health and Social Security. Report to the Secretary of State for Social Services of the informal group on effective prescribing: Greenfield Report. London: Department of Health and Social Security, 1983
17. Erlichman J. If only the watchdog had a bite, a chunk might be taken out of drugs profits. Guardian 1984 Jul 21: 20
18. Department of Health. PPRS: report to Parliament. London: Her Majesty's Stationery Office, 1996 May
19. Rapoport C. No hope of pain relief for companies on Fowlers' prescription. Financial Times 1984 Nov 10: 2
20. Veitch A. Branded ban angers drug firms. Guardian 1984 Nov 10: 2
21. Veitch A. BMA set to boycott talks on NHS Drug List. Guardian 1984 Dec 13: 4
22. Gillie O. Taking medicine. Sunday Times 1984 Dec 16: 16
23. Anderson D. An irregular way to cut costs. The Times 1985 Jan 16: 14
24. Ennals D. Peer view. Health Social Service J 1985 Jan 10: 5
25. Veitch A. Medical college heads refuse to join drug talks. Guardian 1985 Jan 25: 4
26. Vaughan G. Warning - Government can damage your health. Mail on Sunday 1985 Jan 27: 11
27. European Commission. Relating to transparency of measures regulating the scope of natural health insurance schemes [89/105/EEC]. Official J Eur Comm 1989
28. Moyes J, Routledge P, Brace M. Doctors believe secret motive for contraceptive alert is to make money for Government: pill scare saves NHS £25 million. Independent on Sunday 1995 Oct 22: 3
29. Furore over UK oral contraceptive restriction. Scrip 1995 Oct 27; (2072): 25
30. Bligh J, Whalley T. The UK indicative prescribing scheme. PharmacoEconomics 1992; 2: 137-52
31. Whalley T, Wilson R, Bligh J. Current prescribing in primary care in the UK. PharmacoEconomics 1995; 7: 320-31
32. Walker R. Generic medicines: reducing cost at the expense of quality? PharmacoEconomics 1995; 7: 375-7
33. Griffin JP, Griffin TD. The economic implications of therapeutic conservatism. J R Coll Physicians 1993; 27: 121-6
34. Generic prescribing in the UK. Scrip 1996 Apr 30; (2124): 3
35. Griffin JP. Therapeutic conservatism: more costly in the long term? PharmacoEconomics 1995; 7: 378-87
36. Hoffmeyer UK, McCarthy TR. Financing health care. London: Kluwer Academic Publishers, 1994
37. Jones A, Duncan A. Hypothecated health taxes: an evaluation of recent proposals. London: Office of Health Economics, 1995